Abstract
Attenuated retroviruses are currently the most widely used vectors in clinical gene therapy because of their potential to effect stable and permanent gene transfer. Since gene delivery is accompanied by random insertion of foreign genetic material into the recipient chromosomal DNA, the potential for insertional mutagenesis exists. In this study, we used a defective retrovirus vector containing a selectable marker, the hygromycin phosphotransferase gene, to investigate the mutagenic effects of vector integration on the mammalian genome. V79 Chinese hamster cells were infected with virus supernatants or by coculture with virus producer cells, and provirus insertion events occurred at low and high frequencies, respectively. The frequency of hprt mutagenesis was increased by a factor of 2.3 over the spontaneous hprt mutation frequency only following multiple provirus insertions/cell genome. Multiple provirus insertions (>3/genome) resulted in instability at the hprt locus in 63% of the virally induced hprt mutants, as indicated by rearrangements at the molecular level, whereas no rearrangements were found when the provirus copy number was 1–2/genome. To demonstrate direct proviral involvement in mutagenesis, the defective MLV vector was retrieved along with flanking genomic hprt sequences from one mutant, and localized within intron 5 of the hprt gene. These data suggest that provirus copy number is a key factor when considering the potential hazards of using retrovirus vectors for gene therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Miller DG, Rutledge EA, Russell DW . Chromosomal effects of adeno-associated virus vector integration. Nat Genet 2002; 30: 147–148.
Neil JC, Forrest D . Mechanisms of retrovirus-induced leukaemia: selected aspects. Biochim Biophys Acta 1987; 907: 71–91.
Jaenisch R et al. Germline integration of moloney murine leukemia virus at the Mov13 locus leads to recessive lethal mutation and early embryonic death. Cell 1983; 32: 209–216.
Jenkins NA, Copeland NG, Taylor BA, Lee BK . Dilute (d) coat color mutation of DBA/2J mice is associated with the site of integration of an ecotropic MuLV genome. Nature 1981; 293: 370–374.
Selten G et al. Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation. EMBO J 1984; 3: 3215–3222.
Lazo PA, Tsichlis PN . Recombination between two integrated proviruses, one of which was inserted near c-myc in a retrovirus-induced rat thymoma: implications for tumor progression. J Virol 1988; 62: 788–794.
Cuypers HT et al. Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell 1984; 37: 141–150.
Dreyfus F et al. Rearrangements of the Pim-1, c-myc, and p53 genes in Friend helper virus-induced mouse erythroleukemias. Leukemia 1990; 4: 590–594.
Wirschubsky Z, Tsichlis P, Klein G, Sumegi J . Rearrangement of c-myc, pim-1 and Mlvi-1 and trisomy of chromosome 15 in MCF- and Moloney-MuLV-induced murine T-cell leukemias. Int J Cancer 1986; 38: 739–745.
Bergeron D, Poliquin L, Kozak CA, Rassart E . Identification of a common viral integration region in Cas-Br-E murine leukemia virus-induced non-T-, non-B-cell lymphomas. J Virol 1991; 65: 7–15.
Ben-David Y, Lavigueur A, Cheong GY, Bernstein A . Insertional inactivation of the p53 gene during friend leukemia: a new strategy for identifying tumor suppressor genes. New Biol 1990; 2: 1015–1023.
Hicks GG, Mowat M . Integration of Friend murine leukemia virus into both alleles of the p53 oncogene in an erythroleukemic cell line. J Virol 1988; 62: 4752–4755.
Li Z et al. Murine leukemia induced by retroviral gene marking. Science 2002; 296: 497.
Smith JR, Ning Y, Pereira-Smith OM . Why are transformed cells immortal? Is the process reversible? Am J Clin Nutr 1992; 55: 1215S–1221S.
Su YA et al. Reversion of monochromosome-mediated suppression of tumorigenicity in malignant melanoma by retroviral transduction. Cancer Res 1996; 56: 3186–3191.
Tanaka K et al. Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18. Nature 1991; 349: 340–342.
Parris CN et al. Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma. Cancer Res 1999; 59: 516–520.
Goff SP . Insertional mutagenesis to isolate genes. Methods Enzymol 1987; 151: 489–502.
King WMDP, Lobel LI, Goff SP, Nguyen-Huu MC . Insertional mutagenesis of embryonal carcinoma cells by retroviruses. Science 1985; 228: 554–558.
Rossiter BJ et al. The Chinese hamster HPRT gene: restriction map, sequence analysis, and multiplex PCR deletion screen. Genomics 1991; 9: 247–256.
Hayward WS, Neel BG, Astrin SM . Activation of a cellular oncogene by promoter insertion in ALV-induced lymphoid leukosis. Nature 1981; 290: 475–480.
Li Y, Holland CA, Hartley JW, Hopkins N . Viral integration near c-myc in 10–20% of mcf 247-induced AKR lymphomas. Proc Natl Acad Sci USA 1984; 81: 6808–6811.
Zhang LH, Jenssen D . Characterization of HAT- and HAsT-resistant HPRT mutant clones of V79 Chinese hamster cells. Mutat Res 1991; 263: 151–158.
Zhang LH, Jenssen D . Studies on intrachromosomal recombination in SP5/V79 Chinese hamster cells upon exposure to different agents related to carcinogenesis. Carcinogenesis 1994; 15: 2303–2310.
Zhang LH, Vrieling H, van Zeeland AA, Jenssen D . Spectrum of spontaneously occurring mutations in the hprt gene of V79 Chinese hamster cells. J Mol Biol 1992; 223: 627–635.
Kobayashi M, Kawashima A, Mai M, Ooi A . Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization. Am J Pathol 1996; 149: 1575–1584.
Felix CA et al. Association of germline p53 mutation with MLL segmental jumping translocation in treatment-related leukemia. Blood 1998; 91: 4451–4456.
Chou D et al. Accumulation of aberrant Y chromosomes in gamma-ray-induced thymic lymphomas lacking p53. Mol Carcinogen 1999; 26: 157–162.
Lopez-Guerrero JA et al. Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors. Lab Invest 2001; 81: 803–814.
Cheung AM et al. Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosis. Cancer Res 2002; 62: 6194–6204.
Hacein-Bey-Abina S et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003; 348: 255–256.
Check E . A tragic setback. Nature 2002; 420: 116–118.
Grosovsky AJ, Skandalis A, Hasegawa L, Walter BN . Insertional inactivation of the tk locus in a human B lymphoblastoid cell line by a retroviral shuttle vector. Mutat Res 1993; 289: 297–308.
Williams DA, Orkin SH, Mulligan RC . Retrovirus-mediated transfer of human adenosine deaminase gene sequences into cells in culture and into murine hematopoietic cells in vivo. Proc Natl Acad Sci USA 1986; 83: 2566–2570.
Palmer TD, Hock RA, Osborne WR, Miller AD . Efficient retrovirus-mediated transfer and expression of a human adenosine deaminase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human. Proc Natl Acad Sci USA 1987; 84: 1055–1059.
Miller DG, Miller AD . Tunicamycin treatment of CHO cells abrogates multiple blocks to retrovirus infection, one of which is due to a secreted inhibitor. J Virol 1992; 66: 78–84.
Miller AD, Rosman GJ . Improved retroviral vectors for gene transfer and expression. Biotechniques 1989; 7: 980–982, 984–986, 989–990.
Ponce MR, Micol JL . PCR amplification of long DNA fragments. Nucleic Acids Res 1992; 20: 623.
Acknowledgements
We are grateful to Dr JM Cunningham, Dr F Hanaoka and Dr AD Miller for kindly providing the pJET, pSV2bsr and pLHL plasmids, respectively. We also thank our colleagues Dr A Cuthbert and Dr J Arrand for helpful suggestions and support during this work and Dr B Bigger for statistical analysis. This work was supported by Grants from the Cancer Research UK SP2133/0301) and the European Commission (FIGH-CT1999-00002; QLG1-1999-01341).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Themis, M., May, D., Coutelle, C. et al. Mutational effects of retrovirus insertion on the genome of V79 cells by an attenuated retrovirus vector: implications for gene therapy. Gene Ther 10, 1703–1711 (2003). https://doi.org/10.1038/sj.gt.3302059
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302059
Keywords
This article is cited by
-
Gene Therapy for Heart Failure: Where Do We Stand?
Current Cardiology Reports (2013)
-
Effect of endothelial cell-based iNOS gene transfer on cavernosal eNOS expression and mouse erectile responses
International Journal of Impotence Research (2006)